Our Product Portfolio

All our software products are consolidated within one unified core data system that can be used in the interpretation of all areas of human-related disease where genomic information is key to unlock actionable insights and improve patient outcome. 

While we cover a wide range of disease areas, Congenica's software products are also highly customisable and designed to enable rapid analysis and interpretation of next-generation sequencing data at scale, whether on-premise or as SaaS (software as a service).

NGS-driven technological advances in genomics, whether applied prenatally, postnatally or prior to conception, have proven to dramatically improve patient outcomes and reduce costs to healthcare systems. 

To help interpret the often large amount of complex sequencing data that is created, Congenica provides state-of-the-art software products that enable rapid diagnoses in routine clinical care.

Despite advances in biomarker-based drug approvals and availability, NGS-based precision oncology remains underutilised, mainly due to the often large amounts of complex datasets.  To drive the democratisation of Precision Oncology, Congenica is providing fully automated end-to-end solutions for routine oncology clinical practice and highest quality patient support.

In order to manage public health measures effectively, newly emerging pathogens or pathogen variants need to be identified and tracked early.

Congenica's scalable and integrated platform is uniquely placed to enable large-scale analysis to monitor disease outbreaks.